Interaction of fenoterol stereoisomers with β2-adrenoceptor-Gsα fusion proteins: antagonist and agonist competition binding-Reference-Cited by-同舟云学术

Interaction of fenoterol stereoisomers with β2-adrenoceptor-Gsα fusion proteins: antagonist and agonist competition binding

Published:2015-01-31 Issue:5 Volume:388 Page:517-524
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Reinartz Michael T.,Kälble Solveig,Wainer Irving W.,Seifert Roland

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-015-1086-5.pdf

Reference27 articles.

1. Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141–162

2. Chidiac P, Nouet S, Bouvier M (1996) Agonist-induced modulation of inverse agonist efficacy at the β2-adrenergic receptor. Mol Pharmacol 50:662–669

3. Gille A, Seifert R (2003) Co-expression of the β2-adrenoceptor and dopamine D1-receptor with Gsα proteins in Sf9 insect cells: limitations in comparison with fusion proteins. Biochim Biophys Acta 1613:101–114

4. Jozwiak K, Khalid C, Tanga MJ et al (2007) Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the β2-adrenergic receptor. J Med Chem 50:2903–2915

5. Jozwiak K, Toll L, Jimenez L et al (2010a) The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the β2-adrenoceptor. Biochem Pharmacol 79:1610–1615

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RETRACTED ARTICLE: β-Adrenergic receptor structure and function: molecular insights guiding the development of novel therapeutic strategies to treat malignancy;Journal of Receptors and Signal Transduction;2020-05-26

2. β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma;Molecular Biology Reports;2020-04-18

3. Discovery of β-arrestin-biased β2-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives;Acta Pharmacologica Sinica;2019-01-14

4. Naunyn-Schmiedeberg’s Archives of Pharmacology under new editorship: change and continuity;Naunyn-Schmiedeberg's Archives of Pharmacology;2016-05-24

5. Recruitment of β-Arrestin 1 and 2 to the β2-Adrenoceptor: Analysis of 65 Ligands;Journal of Pharmacology and Experimental Therapeutics;2015-08-25